|
Karnosky performance score (KPS)
|
|
>70
|
74 (87.1)
|
|
≤70
|
11 (12.9)
|
|
Gender
|
|
Male
|
78 (91.8)
|
|
Female
|
7 (8.2)
|
|
Age
|
|
Median age
|
50 (28-75)
|
|
Alanine amino transferase ( ALT)(IU/I)
|
|
>40
|
26 (30.6)
|
|
≤40
|
59 (69.4)
|
|
Hemoglobin (HB)(g/L)
|
|
≥120
|
74 (87.1)
|
|
<120
|
11 (12.9)
|
|
Lactate dehydrogenase (LDH) (IU/l)
|
|
>245
|
54 (63.5)
|
|
≤245
|
31 (36.5)
|
|
Alkaline phosphatase (ALP) (IU/l)
|
|
>110
|
28 (32.9)
|
|
≤110
|
57 (67.1)
|
|
T stage (2002AJCC)
|
|
T1-2
|
35 (41.1)
|
|
T3-4
|
50 (58.8)
|
|
N stage (2002AJCC)
|
|
N0-1
|
21 (24.8)
|
|
N2
|
40 (47.1)
|
|
N3
|
24 (28.2)
|
|
No. of metastatic lesion
|
|
≤3
|
35 (41.2)
|
|
>3
|
50 (58.8)
|
|
Size of metastatic lesions (cm)
|
|
≤3
|
53 (62.3)
|
|
>3
|
32 (37.7)
|
|
With extrahepatic metastases
|
|
Yes
|
49 (57.6)
|
|
No
|
36 (42.4)
|
